Avandia Risks Evaluated in Europe by British Medical journal
It's been a while since the US FDA had a meeting of an Advisory Committee to discuss the future in the United States of the diabetes drug rosiglitazone (brand name Avandia), way back in July. Now it's the European's turn to shine the light on rosiglitazone and its troubled safety record:* The BBC's Panorama show ("The world's longest running... Read more



